ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA.
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
Eur J Hum Genet. 2018 Oct;26(10):1521-1536. doi: 10.1038/s41431-018-0196-1. Epub 2018 Jun 11.
RASA1-related disorders are vascular malformation syndromes characterized by hereditary capillary malformations (CM) with or without arteriovenous malformations (AVM), arteriovenous fistulas (AVF), or Parkes Weber syndrome. The number of cases reported is relatively small; and while the main clinical features are CMs and AVMs/AVFs, the broader phenotypic spectrum caused by variants in the RASA1 gene is still being defined. Here, we report the clinical and molecular findings in 69 unrelated cases with a RASA1 variant identified at ARUP Laboratories. Sanger sequencing and multiplex ligation-dependent probe amplification were primarily used to evaluate RASA1. Several atypical cases were evaluated using next-generation sequencing (NGS) and array-comparative genomic hybridization (aCGH). Sixty individuals had a deleterious RASA1 variant of which 29 were novel. Nine individuals had a variant of uncertain significance. Five large RASA1 deletions were detected, giving an overall deletion/duplication rate of 8.3% (5/60) among positive cases. Most (75.4%) individuals with a RASA1 variant had CMs, and 44.9% had an AVM/AVF. Clinical findings in several cases expand the RASA1 phenotype. Our data suggest that screening for large RASA1 deletions and duplications in this disorder is important and suggest that NGS multi-gene panel testing is beneficial for the molecular diagnosis of cases with complex vascular phenotypes.
RASA1 相关疾病是血管畸形综合征,其特征为遗传性毛细血管畸形(CM)伴或不伴动静脉畸形(AVM)、动静脉瘘(AVF)或 Parkes Weber 综合征。报道的病例数量相对较少;虽然主要的临床特征是 CM 和 AVM/AVF,但 RASA1 基因变异引起的更广泛的表型谱仍在定义中。在这里,我们报告了在 ARUP 实验室鉴定出 RASA1 变异的 69 例无关病例的临床和分子发现。Sanger 测序和多重连接依赖性探针扩增主要用于评估 RASA1。使用下一代测序(NGS)和阵列比较基因组杂交(aCGH)评估了几个非典型病例。60 人携带 RASA1 有害变异,其中 29 个为新变异。9 人携带意义不明的变异。检测到 5 个大的 RASA1 缺失,阳性病例中缺失/重复率为 8.3%(5/60)。大多数(75.4%)携带 RASA1 变异的个体有 CM,44.9%有 AVM/AVF。一些病例的临床发现扩展了 RASA1 表型。我们的数据表明,在这种疾病中筛查大的 RASA1 缺失和重复很重要,并表明 NGS 多基因panel 检测有利于对具有复杂血管表型的病例进行分子诊断。